Aurora Private Wealth’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
Aurora Private Wealth's BBC Position: Q2 2026 in Review
Aurora Private Wealth sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2026, closing a stake of 11,376 shares — an estimated $474K sold.
Aurora Private Wealth first reported a position in BBC in Q1 2026 and held it in 1 quarter. The position peaked at $474K in Q1 2026. 3 funds tracked by Wall St. Rank hold BBC as of Q2 2026.
- Aurora Private Wealth reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2026 after selling out during the quarter.
- Aurora Private Wealth sold 11,376 Virtus Biotech Clinical Trials ETF shares in Q2 2026, an estimated $474K.
- Aurora Private Wealth first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2026 and held it in 1 quarter.
- Aurora Private Wealth's Virtus Biotech Clinical Trials ETF position peaked at $474K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.
Based on Aurora Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.